Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer
Authors
Keywords
Chemokines, Colorectal adenocarcinoma, Prognosis, Tumor-infiltrating immune cells
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 89, Issue -, Pages 107077
Publisher
Elsevier BV
Online
2020-10-15
DOI
10.1016/j.intimp.2020.107077
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
- (2019) Yojiro Hashiguchi et al. International Journal of Clinical Oncology
- The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer
- (2019) Xiangde Li et al. PLoS One
- Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma
- (2019) Qing‐Qing Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Pathway Commons 2019 Update: integration, analysis and exploration of pathway data
- (2019) Igor Rodchenkov et al. NUCLEIC ACIDS RESEARCH
- Targeting CXCR1/2: The medicinal potential as cancer immunotherapy agents, antagonists research highlights and challenges ahead
- (2019) Jinxin Che et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
- (2018) Ryuma Tokunaga et al. CANCER TREATMENT REVIEWS
- Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
- (2018) Mana Taki et al. Nature Communications
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity
- (2018) Gianluca D'Agostino et al. Frontiers in Immunology
- The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment
- (2018) Katharina Helene Susek et al. Frontiers in Immunology
- Pathological roles of the homeostatic chemokine CXCL12
- (2018) Rik Janssens et al. CYTOKINE & GROWTH FACTOR REVIEWS
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Targeting both tumour-associated CXCR2+neutrophils and CCR2+macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
- (2017) Timothy M Nywening et al. GUT
- A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive‐disease small cell lung cancer
- (2017) Ravi Salgia et al. LUNG CANCER
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer
- (2017) Larissa Kistner et al. Oncotarget
- Distinct mobilization of leukocytes and hematopoietic stem cells by CXCR4 peptide antagonist LY2510924 and monoclonal antibody LY2624587
- (2017) Sheng-Bin Peng et al. Oncotarget
- IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients
- (2017) Mariantonietta Di Salvatore et al. Oncotarget
- Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade
- (2017) Dirk Zboralski et al. Cancer Immunology Research
- The chemokine CXCL9 expression is associated with better prognosis for colorectal carcinoma patients
- (2016) Zhenqian Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+T Cell Migration into Tumors
- (2016) Zinal S. Chheda et al. JOURNAL OF IMMUNOLOGY
- Tumor-Infiltrating Lymphocytes, Crohn’s-Like Lymphoid Reaction, and Survival From Colorectal Cancer
- (2016) Laura S. Rozek et al. JNCI-Journal of the National Cancer Institute
- Neuroendocrine-like cells -derived CXCL10 and CXCL11 induce the infiltration of tumor-associated macrophage leading to the poor prognosis of colorectal cancer
- (2016) Yu-Jie Zeng et al. Oncotarget
- Tumor-Infiltrating Lymphocytes, Crohn’s-Like Lymphoid Reaction, and Survival From Colorectal Cancer
- (2016) Laura S. Rozek et al. JNCI-Journal of the National Cancer Institute
- CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma
- (2016) T. Chao et al. Cancer Immunology Research
- The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells
- (2016) Wen-Shih Huang et al. PLoS One
- Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival
- (2015) Thibault Desurmont et al. CANCER SCIENCE
- How Do Cytotoxic Lymphocytes Kill Cancer Cells?
- (2015) L. Martinez-Lostao et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment
- (2015) S. Scala CLINICAL CANCER RESEARCH
- CXCR3 ligands in disease and therapy
- (2015) Katrien Van Raemdonck et al. CYTOKINE & GROWTH FACTOR REVIEWS
- CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice
- (2015) Yunching Chen et al. HEPATOLOGY
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration
- (2015) Timothy J. Zumwalt et al. Oncotarget
- CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
- (2015) Zuqiang Liu et al. OncoImmunology
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- Heparanase enhances myeloma progression via CXCL10 downregulation
- (2014) U Barash et al. LEUKEMIA
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CXCL10 mRNA expression predicts response to neoadjuvant chemoradiotherapy in rectal cancer patients
- (2014) Cong Li et al. TUMOR BIOLOGY
- Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
- (2014) Donald Wong et al. BMC Urology
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Role of Chemokines and Chemokine Receptors in Shaping the Effector Phase of the Antitumor Immune Response
- (2012) K. Franciszkiewicz et al. CANCER RESEARCH
- Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma
- (2012) Daruka Mahadevan et al. International Journal of Clinical Oncology
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis
- (2011) Obul R. Bandapalli et al. CYTOKINE
- Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas
- (2010) Jochen Gaedcke et al. GENES CHROMOSOMES & CANCER
- Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
- (2010) Yan Ning et al. INTERNATIONAL JOURNAL OF CANCER
- Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival
- (2010) Dietrich Doll et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Modeling Oncogenic Signaling in Colon Tumors by Multidirectional Analyses of Microarray Data Directed for Maximization of Analytical Reliability
- (2010) Magdalena Skrzypczak et al. PLoS One
- Prognostic Significance of CXCL12 Expression in Patients With Colorectal Carcinoma
- (2009) Yuri Akishima-Fukasawa et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- ELR+ CXC chemokine expression in benign and malignant colorectal conditions
- (2008) Claudia Rubie et al. BMC CANCER
- Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma
- (2008) Kentaro Kurashina et al. CANCER SCIENCE
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started